Corient Private Wealth LP Takes Position in The Cooper Companies, Inc. $COO

Key Points

• Corient Private Wealth LP acquired 22,370 shares of Cooper Companies in the second quarter, valued at approximately $1.6 million. Institutional investors now own 24.39% of the company.
• Cooper Companies exceeded quarterly expectations, reporting $1.21 in earnings per share versus the $1.10 consensus estimate and $1.08 billion in revenue, up 7.9% year over year.
• Analyst sentiment is mixed, with a consensus rating of Hold and an average price target of $81.64, compared with the stock’s recent opening price of $70.64.

Corient Private Wealth LP bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,370 shares of the medical device company's stock, valued at approximately $1,604,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Root Financial Partners LLC increased its holdings in Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock valued at $26,000 after buying an additional 162 shares during the period. Avalon Trust Co bought a new position in shares of Cooper Companies during the 2nd quarter worth about $25,000. SJS Investment Consulting Inc. lifted its holdings in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC boosted its position in shares of Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock valued at $29,000 after acquiring an additional 375 shares in the last quarter. Finally, J.Safra Asset Management Corp acquired a new stake in shares of Cooper Companies during the 2nd quarter valued at about $32,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

COO opened at $70.64 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock has a market capitalization of $13.78 billion, a P/E ratio of 59.86, a price-to-earnings-growth ratio of 1.82 and a beta of 0.82. The company's 50 day simple moving average is $72.74 and its 200-day simple moving average is $70.46. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analysts' expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company's quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.96 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on COO shares. Citigroup restated a "neutral" rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. BNP Paribas Exane lowered their price objective on Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a research note on Monday, June 8th. Needham & Company LLC dropped their target price on Cooper Companies from $101.00 to $86.00 and set a "buy" rating for the company in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a report on Wednesday, May 27th. Finally, Wells Fargo & Company restated a "sell" rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $81.64.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source